Pasadena-based Arrowhead Research has named a new Chief Business Officer, the company announced this morning. Arrowhead said it hs named Brendan P. Rae, Ph.D., J.D, to the position, to lead the firm's licensing and business development efforts. Rae joins from Vivaldi Biosciences, and also had served at VIA Pharmaceuticals, Hoffman-La Roche Ltd., Purdue Pharma L.P, and the law firm of Amster, Rothstein & Ebenstein, LLP.